Skip to main content
Clinical Trials/NCT07347782
NCT07347782Not yet recruitingNot Applicable

Clinical Study on the Efficacy and Reliability of Speech Intelligibility Assessment for Post-stroke Patients Using an AI Solution

Pusan National University Yangsan Hospital0 sites40 target enrollmentStarted: February 1, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
40
Primary Endpoint
Word-level consonant accuracy (%) derived from speech samples obtained during the U-TAP assessment

Study Overview

Brief Summary

compare the auditory-perceptual assessment conducted by speech-language pathologists using the U-TAP with the assessment performed via the AI solution (Blings) program in patients with speech disorders, and to evaluate the efficacy and reliability of these two methods for speech intelligibility assessment.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults aged 18 years or older.
  • Patients with neurologic disorders, including amyotrophic lateral sclerosis, poliomyelitis, cerebellar disorders, cerebellar lesions, and stroke.
  • Patients presenting with concomitant speech disorders, such as dysarthria, motor speech disorders, and voice disorders.

Exclusion Criteria

  • Subjects with a score of less than 16 points on the Korean Mini-Mental State Examination (K-MMSE).
  • Subjects with visual, perceptual, or auditory impairments that prevent them from following the examiner's instructions.
  • Subjects judged by the researcher as unsuitable for participation in this clinical study due to other reasons.

Outcomes

Primary Outcomes

Word-level consonant accuracy (%) derived from speech samples obtained during the U-TAP assessment

Time Frame: Visit 1 (Baseline)

The agreement between consonant accuracy analyzed by the AI-based speech disorder analysis program (Blings) and the evaluations conducted independently by two certified speech-language pathologists (Rater 1 and Rater 2). Consonant accuracy is calculated at the word level and expressed as a percentage score ranging from 0% to 100%. The mean value of consonant accuracy scores from Rater 1 and Rater 2 is used as the reference human evaluation.

Secondary Outcomes

  • Test-retest reliability of word-level consonant accuracy (%) calculated by Blings(Visit 1 and Visit 2 (7 ± 5 days interval))
  • Inter-rater agreement of word-level consonant accuracy (%) among Blings, Rater 1, and Rater 2(Visit 1 and Visit 2 (7 ± 5 days interval))
  • Time required to complete speech analysis (seconds)(Visit 1 and Visit 2 (7 ± 5 days interval))

Investigators

Sponsor
Pusan National University Yangsan Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yong-il Shin

Prof.

Pusan National University Yangsan Hospital

Similar Trials

AI-Based Speech Intelligibility... | Clinical Trial